$Eli Lilly(LLY.US) The guidance given by management is really conservative. Eli Lilly has two major positive catalysts in 2026: 1. The launch of the GLP-1 dual-target oral drug, a groundbreaking product that leads competitors. An oral drug that can help with weight loss without side effects is a historic breakthrough. 2. The inclusion of weight loss drugs in medical insurance. Although the price will decrease, the volume is sure to increase significantly. From a long-term perspective, Eli Lilly's systematic layout in weight loss drugs represents a generational lead that is sustainable. Moreover, it's not just about weight loss drugs; its other products are also industry leaders.👍